Cleared Traditional

K213975 - KEOPS Balance Analyzer 3D
(FDA 510(k) Clearance)

May 2022
Decision
137d
Days
Class 2
Risk

K213975 is an FDA 510(k) clearance for the KEOPS Balance Analyzer 3D. This device is classified as a System, Image Processing, Radiological (Class II - Special Controls, product code LLZ).

Submitted by S.M.A.I.O (Saint Priest, FR). The FDA issued a Cleared decision on May 6, 2022, 137 days after receiving the submission on December 20, 2021.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.2050.

Submission Details

510(k) Number K213975 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 20, 2021
Decision Date May 06, 2022
Days to Decision 137 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code LLZ — System, Image Processing, Radiological
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.2050